1. Home
  2. ZLAB vs BBAR Comparison

ZLAB vs BBAR Comparison

Compare ZLAB & BBAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$25.53

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

BBAR

Banco BBVA Argentina S.A. ADS

N/A

Current Price

$12.41

Market Cap

2.7B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ZLAB
BBAR
Founded
2013
1886
Country
China
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
2017
1997

Fundamental Metrics

Financial Performance
Metric
ZLAB
BBAR
Price
$25.53
$12.41
Analyst Decision
Strong Buy
Buy
Analyst Count
12
4
Target Price
★ $33.14
$25.00
AVG Volume (30 Days)
★ 698.4K
472.4K
Earning Date
11-05-2026
08-27-2026
Dividend Yield
N/A
★ 3.00%
EPS Growth
★ 38.46
N/A
EPS
N/A
★ N/A
Revenue
★ $460,156,000.00
N/A
Revenue This Year
N/A
$55.59
Revenue Next Year
$26.50
$18.23
P/E Ratio
★ N/A
$26.78
Revenue Growth
★ 15.33
N/A
52 Week Low
$15.96
$7.85
52 Week High
$34.07
$22.47

Technical Indicators

Market Signals
Indicator
ZLAB
BBAR
Relative Strength Index (RSI) 58.51 28.19
Support Level $24.81 $12.62
Resistance Level $27.20 $17.05
Average True Range (ATR) 0.77 0.46
MACD -0.03 -0.10
Stochastic Oscillator 76.31 8.94

Price Performance

Historical Comparison
ZLAB
BBAR

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

Share on Social Networks: